The Lantheus Holdings Inc (LNTH) Director Sells $157,500.00 in Stock

The Lantheus Holdings Inc (LNTH) Director Sells $157,500.00 in Stock

Shares of Lantheus Holdings Inc (NASDAQ:LNTH) opened at 16.75 on Monday. The firm has a 50-day moving average price of $14.67 and a 200 day moving average price of $11.35. The company has a market cap of $624.16 million, a P/E ratio of 28.10 and a beta of 0.29. Lantheus Holdings Inc has a 12 month low of $2.15 and a 12 month high of $17.45.

Lantheus Holdings Inc (NASDAQ:LNTH) Director Derace L. Schaffer sold 10,000 shares of Lantheus Holdings stock in a transaction on Wednesday, May 10th. The stock was sold at an average price of $15.75, for a total value of $157,500.00. Following the sale, the director now owns 63,730 shares in the company, valued at $1,003,747.50. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Lantheus Holdings (NASDAQ:LNTH) last issued its quarterly earnings data on Tuesday, May 2nd. The medical equipment provider reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.09. The company had revenue of $81.36 million during the quarter, compared to analyst estimates of $77.75 million. Lantheus Holdings had a negative return on equity of 12.81% and a net margin of 8.64%. Equities analysts predict that Lantheus Holdings Inc will post $0.93 earnings per share for the current year. A number of analysts recently weighed in on LNTH shares. Jefferies Group LLC restated a “buy” rating and issued a $15.00 target price on shares of Lantheus Holdings in a research report on Wednesday, April 26th. Zacks Investment Research upgraded Lantheus Holdings from a “hold” rating to a “strong-buy” rating and set a $17.00 price objective for the company in a research report on Thursday, May 4th.

Hedge funds and other institutional investors have recently modified their holdings of the company. Ativo Capital Management LLC acquired a new position in shares of Lantheus Holdings during the fourth quarter valued at $652,000. Renaissance Technologies LLC raised its position in shares of Lantheus Holdings by 154.6% in the fourth quarter. Renaissance Technologies LLC now owns 393,400 shares of the medical equipment provider’s stock valued at $3,383,000 after buying an additional 238,900 shares during the last quarter. Gabelli Funds LLC raised its position in shares of Lantheus Holdings by 3.8% in the fourth quarter. Gabelli Funds LLC now owns 107,933 shares of the medical equipment provider’s stock valued at $928,000 after buying an additional 3,933 shares during the last quarter. Marshall Wace LLP raised its position in shares of Lantheus Holdings by 35.0% in the fourth quarter. Marshall Wace LLP now owns 456,718 shares of the medical equipment provider’s stock valued at $3,928,000 after buying an additional 118,337 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC raised its position in shares of Lantheus Holdings by 218.9% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 19,463 shares of the medical equipment provider’s stock valued at $167,000 after buying an additional 13,359 shares during the last quarter. Institutional investors own 45.43% of the company’s stock. Lantheus Holdings Company Profile

Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:LNTH”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Related posts

Leave a Comment